Should You Buy ISRG Stock Despite a 13% Fall in Three Months?

robot
Abstract generation in progress

Intuitive Surgical (ISRG) stock has fallen 13.5% in the last three months despite strong procedure growth and adoption of its da Vinci 5 system. The company’s fundamentals, including projected 13-15% global da Vinci procedure growth in 2026 and expansion into new surgical categories, suggest a constructive investment stance. While facing margin headwinds and competitive pressures, ISRG’s market leadership and recurring revenue base position it for continued value creation, leading to a Zacks Rank #1 (Strong Buy).

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)